Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin in Healthy Japanese Volunteers
NCT02949999Phase 1Completed
- Sponsor
- Aurinia
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of voclosporin in lupus nephritis (LN) (5 arms), sponsored by Aurinia. Primary endpoints: Incidence of treatment emergent adverse events at 21 days and Incidence of laboratory parameters outside of normal range at 21 days. Started Oct 2016; status: completed.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT02949999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949999.